Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study.

<h4>Background</h4>Each year, 10%-20% of patients with tuberculosis (TB) in low- and middle-income countries present with previously treated TB and are empirically started on a World Health Organization (WHO)-recommended standardized retreatment regimen. The effectiveness of this retreat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Edward C Jones-López, Irene Ayakaka, Jonathan Levin, Nancy Reilly, Francis Mumbowa, Scott Dryden-Peterson, Grace Nyakoojo, Kevin Fennelly, Beth Temple, Susan Nakubulwa, Moses L Joloba, Alphonse Okwera, Kathleen D Eisenach, Ruth McNerney, Alison M Elliott, Jerrold J Ellner, Peter G Smith, Roy D Mugerwa
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Acceso en línea:https://doaj.org/article/e999a9eaf7974235b085fd0b0a135c12
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e999a9eaf7974235b085fd0b0a135c12
record_format dspace
spelling oai:doaj.org-article:e999a9eaf7974235b085fd0b0a135c122021-11-18T05:41:53ZEffectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study.1549-12771549-167610.1371/journal.pmed.1000427https://doaj.org/article/e999a9eaf7974235b085fd0b0a135c122011-03-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21423586/?tool=EBIhttps://doaj.org/toc/1549-1277https://doaj.org/toc/1549-1676<h4>Background</h4>Each year, 10%-20% of patients with tuberculosis (TB) in low- and middle-income countries present with previously treated TB and are empirically started on a World Health Organization (WHO)-recommended standardized retreatment regimen. The effectiveness of this retreatment regimen has not been systematically evaluated.<h4>Methods and findings</h4>From July 2003 to January 2007, we enrolled smear-positive, pulmonary TB patients into a prospective cohort to study treatment outcomes and mortality during and after treatment with the standardized retreatment regimen. Median time of follow-up was 21 months (interquartile range 12-33 months). A total of 29/148 (20%) HIV-uninfected and 37/140 (26%) HIV-infected patients had an unsuccessful treatment outcome. In a multiple logistic regression analysis to adjust for confounding, factors associated with an unsuccessful treatment outcome were poor adherence (adjusted odds ratio [aOR] associated with missing half or more of scheduled doses 2.39; 95% confidence interval (CI) 1.10-5.22), HIV infection (2.16; 1.01-4.61), age (aOR for 10-year increase 1.59; 1.13-2.25), and duration of TB symptoms (aOR for 1-month increase 1.12; 1.04-1.20). All patients with multidrug-resistant TB had an unsuccessful treatment outcome. HIV-infected individuals were more likely to die than HIV-uninfected individuals (p<0.0001). Multidrug-resistant TB at enrollment was the only common risk factor for death during follow-up for both HIV-infected (adjusted hazard ratio [aHR] 17.9; 6.0-53.4) and HIV-uninfected (14.7; 4.1-52.2) individuals. Other risk factors for death during follow-up among HIV-infected patients were CD4<50 cells/ml and no antiretroviral treatment (aHR 7.4, compared to patients with CD4≥200; 3.0-18.8) and Karnofsky score <70 (2.1; 1.1-4.1); and among HIV-uninfected patients were poor adherence (missing half or more of doses) (3.5; 1.1-10.6) and duration of TB symptoms (aHR for a 1-month increase 1.9; 1.0-3.5).<h4>Conclusions</h4>The recommended regimen for retreatment TB in Uganda yields an unacceptable proportion of unsuccessful outcomes. There is a need to evaluate new treatment strategies in these patients.Edward C Jones-LópezIrene AyakakaJonathan LevinNancy ReillyFrancis MumbowaScott Dryden-PetersonGrace NyakoojoKevin FennellyBeth TempleSusan NakubulwaMoses L JolobaAlphonse OkweraKathleen D EisenachRuth McNerneyAlison M ElliottJerrold J EllnerPeter G SmithRoy D MugerwaPublic Library of Science (PLoS)articleMedicineRENPLoS Medicine, Vol 8, Iss 3, p e1000427 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
Edward C Jones-López
Irene Ayakaka
Jonathan Levin
Nancy Reilly
Francis Mumbowa
Scott Dryden-Peterson
Grace Nyakoojo
Kevin Fennelly
Beth Temple
Susan Nakubulwa
Moses L Joloba
Alphonse Okwera
Kathleen D Eisenach
Ruth McNerney
Alison M Elliott
Jerrold J Ellner
Peter G Smith
Roy D Mugerwa
Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study.
description <h4>Background</h4>Each year, 10%-20% of patients with tuberculosis (TB) in low- and middle-income countries present with previously treated TB and are empirically started on a World Health Organization (WHO)-recommended standardized retreatment regimen. The effectiveness of this retreatment regimen has not been systematically evaluated.<h4>Methods and findings</h4>From July 2003 to January 2007, we enrolled smear-positive, pulmonary TB patients into a prospective cohort to study treatment outcomes and mortality during and after treatment with the standardized retreatment regimen. Median time of follow-up was 21 months (interquartile range 12-33 months). A total of 29/148 (20%) HIV-uninfected and 37/140 (26%) HIV-infected patients had an unsuccessful treatment outcome. In a multiple logistic regression analysis to adjust for confounding, factors associated with an unsuccessful treatment outcome were poor adherence (adjusted odds ratio [aOR] associated with missing half or more of scheduled doses 2.39; 95% confidence interval (CI) 1.10-5.22), HIV infection (2.16; 1.01-4.61), age (aOR for 10-year increase 1.59; 1.13-2.25), and duration of TB symptoms (aOR for 1-month increase 1.12; 1.04-1.20). All patients with multidrug-resistant TB had an unsuccessful treatment outcome. HIV-infected individuals were more likely to die than HIV-uninfected individuals (p<0.0001). Multidrug-resistant TB at enrollment was the only common risk factor for death during follow-up for both HIV-infected (adjusted hazard ratio [aHR] 17.9; 6.0-53.4) and HIV-uninfected (14.7; 4.1-52.2) individuals. Other risk factors for death during follow-up among HIV-infected patients were CD4<50 cells/ml and no antiretroviral treatment (aHR 7.4, compared to patients with CD4≥200; 3.0-18.8) and Karnofsky score <70 (2.1; 1.1-4.1); and among HIV-uninfected patients were poor adherence (missing half or more of doses) (3.5; 1.1-10.6) and duration of TB symptoms (aHR for a 1-month increase 1.9; 1.0-3.5).<h4>Conclusions</h4>The recommended regimen for retreatment TB in Uganda yields an unacceptable proportion of unsuccessful outcomes. There is a need to evaluate new treatment strategies in these patients.
format article
author Edward C Jones-López
Irene Ayakaka
Jonathan Levin
Nancy Reilly
Francis Mumbowa
Scott Dryden-Peterson
Grace Nyakoojo
Kevin Fennelly
Beth Temple
Susan Nakubulwa
Moses L Joloba
Alphonse Okwera
Kathleen D Eisenach
Ruth McNerney
Alison M Elliott
Jerrold J Ellner
Peter G Smith
Roy D Mugerwa
author_facet Edward C Jones-López
Irene Ayakaka
Jonathan Levin
Nancy Reilly
Francis Mumbowa
Scott Dryden-Peterson
Grace Nyakoojo
Kevin Fennelly
Beth Temple
Susan Nakubulwa
Moses L Joloba
Alphonse Okwera
Kathleen D Eisenach
Ruth McNerney
Alison M Elliott
Jerrold J Ellner
Peter G Smith
Roy D Mugerwa
author_sort Edward C Jones-López
title Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study.
title_short Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study.
title_full Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study.
title_fullStr Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study.
title_full_unstemmed Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study.
title_sort effectiveness of the standard who recommended retreatment regimen (category ii) for tuberculosis in kampala, uganda: a prospective cohort study.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/e999a9eaf7974235b085fd0b0a135c12
work_keys_str_mv AT edwardcjoneslopez effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
AT ireneayakaka effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
AT jonathanlevin effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
AT nancyreilly effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
AT francismumbowa effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
AT scottdrydenpeterson effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
AT gracenyakoojo effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
AT kevinfennelly effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
AT bethtemple effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
AT susannakubulwa effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
AT mosesljoloba effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
AT alphonseokwera effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
AT kathleendeisenach effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
AT ruthmcnerney effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
AT alisonmelliott effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
AT jerroldjellner effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
AT petergsmith effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
AT roydmugerwa effectivenessofthestandardwhorecommendedretreatmentregimencategoryiifortuberculosisinkampalaugandaaprospectivecohortstudy
_version_ 1718424886888628224